Radiopharmaceutical therapy (RPT) is emerging as a safe and effective targeted approach
to treating many types of cancer. In RPT, radiation is systemically or locally delivered using …

The discovery of the medicinal properties of gold complexes has fuelled the design and
synthesis of new anticancer metallodrugs, which have received special attention due to their …

While the development of positron emission tomography (PET) radiopharmaceuticals
closely follows that of traditional drug development, there are several key considerations in …

Molecular changes in malignant tissue can lead to an increase in the expression levels of
various proteins or receptors that can be used to target the disease. In oncology, diagnostic …

Oral disease, as a class of diseases with very high morbidity, brings great physical and
mental damage to people worldwide. The increasing burden and strain on individuals and …

The incorporation of silicon fluoride acceptor (SiFA) moieties into a variety of molecules,
such as peptides, proteins and biologically relevant small molecules, has improved the …

Introduction Prostate and breast cancer represent a leading cause of cancer-related death
worldwide with a dramatic social and demographic impact. Gastrin-releasing peptide …

Oral squamous cell carcinoma (OSCC) is the most common malignant tumor that occurs in
the oral mucosa. Pathological biopsy is still the current gold standard for OSCC diagnosis; …

G-protein-coupled receptors (GPCRs) are increasingly being considered as possible
therapeutic targets in cancers. Activation of GPCR on tumors can have prominent growth …

Breast cancer is one of the most common malignancies in women, with high morbidity and
mortality rates. In breast cancer, the use of novel radiopharmaceuticals in nuclear medicine …